The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
The global Carmustine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Carmustine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Carmustine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Carmustine include Amneal Pharms, Arbor Pharms, Emcure Pharms, Navinta, STI Pharma, Obvius Pharmaceuticals, MGI Pharma, Marcan Pharmaceuticals and Eisai, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Carmustine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Carmustine.
Report Scope
The Carmustine market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Carmustine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Carmustine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Amneal Pharms
Arbor Pharms
Emcure Pharms
Navinta
STI Pharma
Obvius Pharmaceuticals
MGI Pharma
Marcan Pharmaceuticals
Eisai
Bristol-Myers Squibb
Pharmaplan
Sanli Ilac
Zydus Pharmaceuticals
Tianjin Kingyork
Segment by Type
100mg Injection
125mg Injection
Segment by Application
Glioma
Glioblastoma Multiforme
Medulloblastoma and Astrocytoma
Multiple Myeloma
Lymphoma
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Carmustine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Carmustine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Carmustine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Carmustine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Carmustine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Carmustine include Amneal Pharms, Arbor Pharms, Emcure Pharms, Navinta, STI Pharma, Obvius Pharmaceuticals, MGI Pharma, Marcan Pharmaceuticals and Eisai, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Carmustine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Carmustine.
Report Scope
The Carmustine market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Carmustine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Carmustine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Amneal Pharms
Arbor Pharms
Emcure Pharms
Navinta
STI Pharma
Obvius Pharmaceuticals
MGI Pharma
Marcan Pharmaceuticals
Eisai
Bristol-Myers Squibb
Pharmaplan
Sanli Ilac
Zydus Pharmaceuticals
Tianjin Kingyork
Segment by Type
100mg Injection
125mg Injection
Segment by Application
Glioma
Glioblastoma Multiforme
Medulloblastoma and Astrocytoma
Multiple Myeloma
Lymphoma
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Carmustine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Carmustine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Carmustine Market Overview
1.1 Product Overview and Scope of Carmustine
1.2 Carmustine Segment by Type
1.2.1 Global Carmustine Market Value Comparison by Type (2024-2030)
1.2.2 100mg Injection
1.2.3 125mg Injection
1.3 Carmustine Segment by Application
1.3.1 Global Carmustine Market Value by Application: (2024-2030)
1.3.2 Glioma
1.3.3 Glioblastoma Multiforme
1.3.4 Medulloblastoma and Astrocytoma
1.3.5 Multiple Myeloma
1.3.6 Lymphoma
1.3.7 Others
1.4 Global Carmustine Market Size Estimates and Forecasts
1.4.1 Global Carmustine Revenue 2019-2030
1.4.2 Global Carmustine Sales 2019-2030
1.4.3 Global Carmustine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Carmustine Market Competition by Manufacturers
2.1 Global Carmustine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Carmustine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Carmustine Average Price by Manufacturers (2019-2024)
2.4 Global Carmustine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Carmustine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Carmustine, Product Type & Application
2.7 Carmustine Market Competitive Situation and Trends
2.7.1 Carmustine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Carmustine Players Market Share by Revenue
2.7.3 Global Carmustine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Carmustine Retrospective Market Scenario by Region
3.1 Global Carmustine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Carmustine Global Carmustine Sales by Region: 2019-2030
3.2.1 Global Carmustine Sales by Region: 2019-2024
3.2.2 Global Carmustine Sales by Region: 2025-2030
3.3 Global Carmustine Global Carmustine Revenue by Region: 2019-2030
3.3.1 Global Carmustine Revenue by Region: 2019-2024
3.3.2 Global Carmustine Revenue by Region: 2025-2030
3.4 North America Carmustine Market Facts & Figures by Country
3.4.1 North America Carmustine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Carmustine Sales by Country (2019-2030)
3.4.3 North America Carmustine Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Carmustine Market Facts & Figures by Country
3.5.1 Europe Carmustine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Carmustine Sales by Country (2019-2030)
3.5.3 Europe Carmustine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Carmustine Market Facts & Figures by Country
3.6.1 Asia Pacific Carmustine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Carmustine Sales by Country (2019-2030)
3.6.3 Asia Pacific Carmustine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Carmustine Market Facts & Figures by Country
3.7.1 Latin America Carmustine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Carmustine Sales by Country (2019-2030)
3.7.3 Latin America Carmustine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Carmustine Market Facts & Figures by Country
3.8.1 Middle East and Africa Carmustine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Carmustine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Carmustine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Carmustine Sales by Type (2019-2030)
4.1.1 Global Carmustine Sales by Type (2019-2024)
4.1.2 Global Carmustine Sales by Type (2025-2030)
4.1.3 Global Carmustine Sales Market Share by Type (2019-2030)
4.2 Global Carmustine Revenue by Type (2019-2030)
4.2.1 Global Carmustine Revenue by Type (2019-2024)
4.2.2 Global Carmustine Revenue by Type (2025-2030)
4.2.3 Global Carmustine Revenue Market Share by Type (2019-2030)
4.3 Global Carmustine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Carmustine Sales by Application (2019-2030)
5.1.1 Global Carmustine Sales by Application (2019-2024)
5.1.2 Global Carmustine Sales by Application (2025-2030)
5.1.3 Global Carmustine Sales Market Share by Application (2019-2030)
5.2 Global Carmustine Revenue by Application (2019-2030)
5.2.1 Global Carmustine Revenue by Application (2019-2024)
5.2.2 Global Carmustine Revenue by Application (2025-2030)
5.2.3 Global Carmustine Revenue Market Share by Application (2019-2030)
5.3 Global Carmustine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Amneal Pharms
6.1.1 Amneal Pharms Corporation Information
6.1.2 Amneal Pharms Description and Business Overview
6.1.3 Amneal Pharms Carmustine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Amneal Pharms Carmustine Product Portfolio
6.1.5 Amneal Pharms Recent Developments/Updates
6.2 Arbor Pharms
6.2.1 Arbor Pharms Corporation Information
6.2.2 Arbor Pharms Description and Business Overview
6.2.3 Arbor Pharms Carmustine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Arbor Pharms Carmustine Product Portfolio
6.2.5 Arbor Pharms Recent Developments/Updates
6.3 Emcure Pharms
6.3.1 Emcure Pharms Corporation Information
6.3.2 Emcure Pharms Description and Business Overview
6.3.3 Emcure Pharms Carmustine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Emcure Pharms Carmustine Product Portfolio
6.3.5 Emcure Pharms Recent Developments/Updates
6.4 Navinta
6.4.1 Navinta Corporation Information
6.4.2 Navinta Description and Business Overview
6.4.3 Navinta Carmustine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Navinta Carmustine Product Portfolio
6.4.5 Navinta Recent Developments/Updates
6.5 STI Pharma
6.5.1 STI Pharma Corporation Information
6.5.2 STI Pharma Description and Business Overview
6.5.3 STI Pharma Carmustine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 STI Pharma Carmustine Product Portfolio
6.5.5 STI Pharma Recent Developments/Updates
6.6 Obvius Pharmaceuticals
6.6.1 Obvius Pharmaceuticals Corporation Information
6.6.2 Obvius Pharmaceuticals Description and Business Overview
6.6.3 Obvius Pharmaceuticals Carmustine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Obvius Pharmaceuticals Carmustine Product Portfolio
6.6.5 Obvius Pharmaceuticals Recent Developments/Updates
6.7 MGI Pharma
6.6.1 MGI Pharma Corporation Information
6.6.2 MGI Pharma Description and Business Overview
6.6.3 MGI Pharma Carmustine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 MGI Pharma Carmustine Product Portfolio
6.7.5 MGI Pharma Recent Developments/Updates
6.8 Marcan Pharmaceuticals
6.8.1 Marcan Pharmaceuticals Corporation Information
6.8.2 Marcan Pharmaceuticals Description and Business Overview
6.8.3 Marcan Pharmaceuticals Carmustine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Marcan Pharmaceuticals Carmustine Product Portfolio
6.8.5 Marcan Pharmaceuticals Recent Developments/Updates
6.9 Eisai
6.9.1 Eisai Corporation Information
6.9.2 Eisai Description and Business Overview
6.9.3 Eisai Carmustine Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Eisai Carmustine Product Portfolio
6.9.5 Eisai Recent Developments/Updates
6.10 Bristol-Myers Squibb
6.10.1 Bristol-Myers Squibb Corporation Information
6.10.2 Bristol-Myers Squibb Description and Business Overview
6.10.3 Bristol-Myers Squibb Carmustine Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Bristol-Myers Squibb Carmustine Product Portfolio
6.10.5 Bristol-Myers Squibb Recent Developments/Updates
6.11 Pharmaplan
6.11.1 Pharmaplan Corporation Information
6.11.2 Pharmaplan Carmustine Description and Business Overview
6.11.3 Pharmaplan Carmustine Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Pharmaplan Carmustine Product Portfolio
6.11.5 Pharmaplan Recent Developments/Updates
6.12 Sanli Ilac
6.12.1 Sanli Ilac Corporation Information
6.12.2 Sanli Ilac Carmustine Description and Business Overview
6.12.3 Sanli Ilac Carmustine Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Sanli Ilac Carmustine Product Portfolio
6.12.5 Sanli Ilac Recent Developments/Updates
6.13 Zydus Pharmaceuticals
6.13.1 Zydus Pharmaceuticals Corporation Information
6.13.2 Zydus Pharmaceuticals Carmustine Description and Business Overview
6.13.3 Zydus Pharmaceuticals Carmustine Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Zydus Pharmaceuticals Carmustine Product Portfolio
6.13.5 Zydus Pharmaceuticals Recent Developments/Updates
6.14 Tianjin Kingyork
6.14.1 Tianjin Kingyork Corporation Information
6.14.2 Tianjin Kingyork Carmustine Description and Business Overview
6.14.3 Tianjin Kingyork Carmustine Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Tianjin Kingyork Carmustine Product Portfolio
6.14.5 Tianjin Kingyork Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Carmustine Industry Chain Analysis
7.2 Carmustine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Carmustine Production Mode & Process
7.4 Carmustine Sales and Marketing
7.4.1 Carmustine Sales Channels
7.4.2 Carmustine Distributors
7.5 Carmustine Customers
8 Carmustine Market Dynamics
8.1 Carmustine Industry Trends
8.2 Carmustine Market Drivers
8.3 Carmustine Market Challenges
8.4 Carmustine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Carmustine Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Carmustine Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Carmustine Market Competitive Situation by Manufacturers in 2023
Table 4. Global Carmustine Sales (K Pcs) of Key Manufacturers (2019-2024)
Table 5. Global Carmustine Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Carmustine Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Carmustine Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Carmustine Average Price (USD/Pcs) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Carmustine, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Carmustine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Carmustine, Product Type & Application
Table 12. Global Key Manufacturers of Carmustine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Carmustine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Carmustine as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Carmustine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Carmustine Sales by Region (2019-2024) & (K Pcs)
Table 18. Global Carmustine Sales Market Share by Region (2019-2024)
Table 19. Global Carmustine Sales by Region (2025-2030) & (K Pcs)
Table 20. Global Carmustine Sales Market Share by Region (2025-2030)
Table 21. Global Carmustine Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Carmustine Revenue Market Share by Region (2019-2024)
Table 23. Global Carmustine Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Carmustine Revenue Market Share by Region (2025-2030)
Table 25. North America Carmustine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Carmustine Sales by Country (2019-2024) & (K Pcs)
Table 27. North America Carmustine Sales by Country (2025-2030) & (K Pcs)
Table 28. North America Carmustine Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Carmustine Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Carmustine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Carmustine Sales by Country (2019-2024) & (K Pcs)
Table 32. Europe Carmustine Sales by Country (2025-2030) & (K Pcs)
Table 33. Europe Carmustine Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Carmustine Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Carmustine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Carmustine Sales by Region (2019-2024) & (K Pcs)
Table 37. Asia Pacific Carmustine Sales by Region (2025-2030) & (K Pcs)
Table 38. Asia Pacific Carmustine Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Carmustine Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Carmustine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Carmustine Sales by Country (2019-2024) & (K Pcs)
Table 42. Latin America Carmustine Sales by Country (2025-2030) & (K Pcs)
Table 43. Latin America Carmustine Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Carmustine Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Carmustine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Carmustine Sales by Country (2019-2024) & (K Pcs)
Table 47. Middle East & Africa Carmustine Sales by Country (2025-2030) & (K Pcs)
Table 48. Middle East & Africa Carmustine Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Carmustine Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Carmustine Sales (K Pcs) by Type (2019-2024)
Table 51. Global Carmustine Sales (K Pcs) by Type (2025-2030)
Table 52. Global Carmustine Sales Market Share by Type (2019-2024)
Table 53. Global Carmustine Sales Market Share by Type (2025-2030)
Table 54. Global Carmustine Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Carmustine Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Carmustine Revenue Market Share by Type (2019-2024)
Table 57. Global Carmustine Revenue Market Share by Type (2025-2030)
Table 58. Global Carmustine Price (USD/Pcs) by Type (2019-2024)
Table 59. Global Carmustine Price (USD/Pcs) by Type (2025-2030)
Table 60. Global Carmustine Sales (K Pcs) by Application (2019-2024)
Table 61. Global Carmustine Sales (K Pcs) by Application (2025-2030)
Table 62. Global Carmustine Sales Market Share by Application (2019-2024)
Table 63. Global Carmustine Sales Market Share by Application (2025-2030)
Table 64. Global Carmustine Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Carmustine Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Carmustine Revenue Market Share by Application (2019-2024)
Table 67. Global Carmustine Revenue Market Share by Application (2025-2030)
Table 68. Global Carmustine Price (USD/Pcs) by Application (2019-2024)
Table 69. Global Carmustine Price (USD/Pcs) by Application (2025-2030)
Table 70. Amneal Pharms Corporation Information
Table 71. Amneal Pharms Description and Business Overview
Table 72. Amneal Pharms Carmustine Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 73. Amneal Pharms Carmustine Product
Table 74. Amneal Pharms Recent Developments/Updates
Table 75. Arbor Pharms Corporation Information
Table 76. Arbor Pharms Description and Business Overview
Table 77. Arbor Pharms Carmustine Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 78. Arbor Pharms Carmustine Product
Table 79. Arbor Pharms Recent Developments/Updates
Table 80. Emcure Pharms Corporation Information
Table 81. Emcure Pharms Description and Business Overview
Table 82. Emcure Pharms Carmustine Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 83. Emcure Pharms Carmustine Product
Table 84. Emcure Pharms Recent Developments/Updates
Table 85. Navinta Corporation Information
Table 86. Navinta Description and Business Overview
Table 87. Navinta Carmustine Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 88. Navinta Carmustine Product
Table 89. Navinta Recent Developments/Updates
Table 90. STI Pharma Corporation Information
Table 91. STI Pharma Description and Business Overview
Table 92. STI Pharma Carmustine Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 93. STI Pharma Carmustine Product
Table 94. STI Pharma Recent Developments/Updates
Table 95. Obvius Pharmaceuticals Corporation Information
Table 96. Obvius Pharmaceuticals Description and Business Overview
Table 97. Obvius Pharmaceuticals Carmustine Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 98. Obvius Pharmaceuticals Carmustine Product
Table 99. Obvius Pharmaceuticals Recent Developments/Updates
Table 100. MGI Pharma Corporation Information
Table 101. MGI Pharma Description and Business Overview
Table 102. MGI Pharma Carmustine Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 103. MGI Pharma Carmustine Product
Table 104. MGI Pharma Recent Developments/Updates
Table 105. Marcan Pharmaceuticals Corporation Information
Table 106. Marcan Pharmaceuticals Description and Business Overview
Table 107. Marcan Pharmaceuticals Carmustine Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 108. Marcan Pharmaceuticals Carmustine Product
Table 109. Marcan Pharmaceuticals Recent Developments/Updates
Table 110. Eisai Corporation Information
Table 111. Eisai Description and Business Overview
Table 112. Eisai Carmustine Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 113. Eisai Carmustine Product
Table 114. Eisai Recent Developments/Updates
Table 115. Bristol-Myers Squibb Corporation Information
Table 116. Bristol-Myers Squibb Description and Business Overview
Table 117. Bristol-Myers Squibb Carmustine Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 118. Bristol-Myers Squibb Carmustine Product
Table 119. Bristol-Myers Squibb Recent Developments/Updates
Table 120. Pharmaplan Corporation Information
Table 121. Pharmaplan Description and Business Overview
Table 122. Pharmaplan Carmustine Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 123. Pharmaplan Carmustine Product
Table 124. Pharmaplan Recent Developments/Updates
Table 125. Sanli Ilac Corporation Information
Table 126. Sanli Ilac Description and Business Overview
Table 127. Sanli Ilac Carmustine Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 128. Sanli Ilac Carmustine Product
Table 129. Sanli Ilac Recent Developments/Updates
Table 130. Zydus Pharmaceuticals Corporation Information
Table 131. Zydus Pharmaceuticals Description and Business Overview
Table 132. Zydus Pharmaceuticals Carmustine Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 133. Zydus Pharmaceuticals Carmustine Product
Table 134. Zydus Pharmaceuticals Recent Developments/Updates
Table 135. Tianjin Kingyork Corporation Information
Table 136. Tianjin Kingyork Description and Business Overview
Table 137. Tianjin Kingyork Carmustine Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 138. Tianjin Kingyork Carmustine Product
Table 139. Tianjin Kingyork Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Carmustine Distributors List
Table 143. Carmustine Customers List
Table 144. Carmustine Market Trends
Table 145. Carmustine Market Drivers
Table 146. Carmustine Market Challenges
Table 147. Carmustine Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Carmustine
Figure 2. Global Carmustine Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Carmustine Market Share by Type in 2023 & 2030
Figure 4. 100mg Injection Product Picture
Figure 5. 125mg Injection Product Picture
Figure 6. Global Carmustine Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Carmustine Market Share by Application in 2023 & 2030
Figure 8. Glioma
Figure 9. Glioblastoma Multiforme
Figure 10. Medulloblastoma and Astrocytoma
Figure 11. Multiple Myeloma
Figure 12. Lymphoma
Figure 13. Others
Figure 14. Global Carmustine Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Carmustine Market Size (2019-2030) & (US$ Million)
Figure 16. Global Carmustine Sales (2019-2030) & (K Pcs)
Figure 17. Global Carmustine Average Price (USD/Pcs) & (2019-2030)
Figure 18. Carmustine Report Years Considered
Figure 19. Carmustine Sales Share by Manufacturers in 2023
Figure 20. Global Carmustine Revenue Share by Manufacturers in 2023
Figure 21. The Global 5 and 10 Largest Carmustine Players: Market Share by Revenue in 2023
Figure 22. Carmustine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 23. Global Carmustine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 24. North America Carmustine Sales Market Share by Country (2019-2030)
Figure 25. North America Carmustine Revenue Market Share by Country (2019-2030)
Figure 26. U.S. Carmustine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Canada Carmustine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. Europe Carmustine Sales Market Share by Country (2019-2030)
Figure 29. Europe Carmustine Revenue Market Share by Country (2019-2030)
Figure 30. Germany Carmustine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. France Carmustine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. U.K. Carmustine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Italy Carmustine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Russia Carmustine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Asia Pacific Carmustine Sales Market Share by Region (2019-2030)
Figure 36. Asia Pacific Carmustine Revenue Market Share by Region (2019-2030)
Figure 37. China Carmustine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Japan Carmustine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. South Korea Carmustine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. India Carmustine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Australia Carmustine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Taiwan Carmustine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Indonesia Carmustine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Thailand Carmustine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Malaysia Carmustine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Philippines Carmustine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Latin America Carmustine Sales Market Share by Country (2019-2030)
Figure 48. Latin America Carmustine Revenue Market Share by Country (2019-2030)
Figure 49. Mexico Carmustine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Brazil Carmustine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Argentina Carmustine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Middle East & Africa Carmustine Sales Market Share by Country (2019-2030)
Figure 53. Middle East & Africa Carmustine Revenue Market Share by Country (2019-2030)
Figure 54. Turkey Carmustine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Saudi Arabia Carmustine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. U.A.E Carmustine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 57. Global Sales Market Share of Carmustine by Type (2019-2030)
Figure 58. Global Revenue Market Share of Carmustine by Type (2019-2030)
Figure 59. Global Carmustine Price (USD/Pcs) by Type (2019-2030)
Figure 60. Global Sales Market Share of Carmustine by Application (2019-2030)
Figure 61. Global Revenue Market Share of Carmustine by Application (2019-2030)
Figure 62. Global Carmustine Price (USD/Pcs) by Application (2019-2030)
Figure 63. Carmustine Value Chain
Figure 64. Carmustine Production Process
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Distributors Profiles
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
